Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06344338
NA

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

Sponsor: Xuanwu Hospital, Beijing

View on ClinicalTrials.gov

Summary

The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus

Official title: Application of Targeting Transcranial Direct Current Stimulation (tDCS) Stimulation in the Treatment of Refractory Status Epilepticus

Key Details

Gender

All

Age Range

14 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2024-04-01

Completion Date

2025-03-31

Last Updated

2024-07-31

Healthy Volunteers

No

Interventions

DEVICE

tDCS stimulation

In the real-stimulation group, Treatment was for 20 min, repeated twice in a day, then again over the next few days. The maximum number of stimuli required to terminate the status epilepticus should not exceed 10. In the sham-stimulation group, The duration and frequency of tDCS are the same as those in the treatment group, but the tDCS device is not active during the 20 minutes of sham-stimulation

DEVICE

TDCS sham-stimulation

TDCS sham-stimulation

Locations (1)

Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality, China